NIH AI Discovered Three Breakthrough Drugs for Alzheimer's and Parkinson's in 18 Months
The National Institutes of Health's AI-driven drug repurposing initiative has identified three FDA-approved compounds that show powerful neuroprotective effects — potentially cutting the development timeline for new Alzheimer's and Parkinson's treatments by decades.


